Leerink Swann Reaffirms “Outperform” Rating for Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ:ISRG)‘s stock had its “outperform” rating reissued by equities research analysts at Leerink Swann in a research note issued on Thursday, Marketbeat reports. They presently have a $475.00 price objective on the medical equipment provider’s stock, up from their previous price objective of $390.00. Leerink Swann’s price target suggests a potential upside of 9.64% from the company’s current price.

ISRG has been the topic of several other reports. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 price objective on the stock in a research report on Tuesday, November 14th. Evercore ISI started coverage on shares of Intuitive Surgical in a research report on Wednesday, January 3rd. They issued an “in-line” rating and a $380.00 price objective on the stock. BidaskClub raised shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 11th. Finally, Canaccord Genuity reissued a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday, October 17th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $368.71.

Shares of Intuitive Surgical (NASDAQ:ISRG) traded up $1.16 during midday trading on Thursday, hitting $433.23. 727,593 shares of the stock traded hands, compared to its average volume of 919,870. The stock has a market cap of $48,540.00, a PE ratio of 55.97, a price-to-earnings-growth ratio of 5.39 and a beta of 0.47. Intuitive Surgical has a 52-week low of $217.19 and a 52-week high of $436.57.

In other Intuitive Surgical news, insider Craig H. Barratt sold 15,000 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $371.18, for a total value of $5,567,700.00. Following the transaction, the insider now directly owns 7,500 shares in the company, valued at approximately $2,783,850. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $400.00, for a total transaction of $1,200,000.00. Following the completion of the transaction, the senior vice president now owns 9,888 shares in the company, valued at $3,955,200. The disclosure for this sale can be found here. Insiders sold a total of 55,944 shares of company stock worth $21,432,971 over the last 90 days. Insiders own 2.20% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Stifel Financial Corp boosted its stake in shares of Intuitive Surgical by 11.2% during the second quarter. Stifel Financial Corp now owns 8,356 shares of the medical equipment provider’s stock valued at $7,837,000 after purchasing an additional 841 shares in the last quarter. First Trust Advisors LP lifted its position in Intuitive Surgical by 61.4% during the third quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock valued at $53,476,000 after acquiring an additional 19,458 shares during the last quarter. Davis R M Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $219,000. Point72 Asset Management L.P. purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $24,264,000. Finally, Tower Research Capital LLC TRC lifted its position in Intuitive Surgical by 122.0% during the second quarter. Tower Research Capital LLC TRC now owns 819 shares of the medical equipment provider’s stock valued at $766,000 after acquiring an additional 450 shares during the last quarter. Hedge funds and other institutional investors own 32.82% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/21/leerink-swann-reaffirms-outperform-rating-for-intuitive-surgical-isrg.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply